The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. Antares Pharma, Inc. (NASDAQ:ATRS) has a beta value of 1.39 and has seen 1,428,722 shares traded in the last trading session. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy." 4 Wall Street analysts have issued ratings and price targets for Antares Pharma in the last 12 months. Volume today is low. The beta is 1.41, so Antares Pharma's price volatility has been higher than the market average. BidaskClub upgraded shares of Antares Pharma (NASDAQ:ATRS) from a hold rating to a buy rating in a research report sent to investors on Thursday, BidAskClub reports. Mar-06-19 07:00AM : Antares Pharma to Present at the Cowen and Company 39th Annual Healthcare Conference . One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. View daily, weekly or monthly format back to when Antares Pharma, Inc. stock was issued. If you had put $1,000 dollars into Antares Pharma stock , it would be worth today. low after FDA letter late Thursday. Antares Pharma, Inc. (US:ATRS) has 302 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). Antares Pharma Inc. (NASDAQ:ATRS) went down by -0.87% from its latest closing price compared to the recent 1-year high of $4.90. A look at the daily price movement … The price/operating cash flow metric for Antares Pharma Inc is higher than 90.4% of stocks in our set with a positive cash flow. Press Release reported on 11/23/20 that Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference Antares Pharma, Inc. (NASDAQ:ATRS) concluded the trading at $3.99 on Thursday, Dec 17 with a rise of 2.05% from its closing price on previous day. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Antares Pharma share forecasts, stock quote and buy / sell signals below.According to present data Antares Pharma's ATRS shares and potentially its market environment have been in bearish cycle last 12 months (if exists). Antares Pharma stock price ended on $3.99 on Thursday after gaining 2.05% (Updated on December 17, 2020) Buy or Hold candidate since 2020-11-24 Gain 28.71% PDF . Antares Pharma, Inc. (NASDAQ:ATRS) price closed higher on Tuesday, Nov 24, jumping 8.39% above its previous close. Stock Price Statistics. ANTARES PHARMA, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for ANTARES PHARMA, INC. Stock | ATRS | For now, the stock … Antares Pharma, Inc. Common Stock (ATRS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Oct. 13, 2017 at 7:57 a.m. View today's stock price, news and analysis for Antares Pharma Inc. (ATRS). Feb-28-19 12:31PM : Antares Pharma Inc (ATRS) … Register now to create your own custom streaming stock watchlist. The company was … Antares Pharma (NASDAQ:ATRS), GreenSky ... Antares has traded at penny-stock levels for more than 20 years, so this growth could serve as a long-awaited catalyst. Click here now. ATRS has been the topic of several other research reports. Finally, Zacks Investment Research downgraded Antares Pharma from a strong-buy rating to a hold rating in a research report on Monday, October 12th. The company has a market capitalization of $664.98 Million. Antares Pharma, Inc. (NASDAQ:ATRS) Antares Pharma, Inc. (NASDAQ:ATRS) closed at $3.87 on the last trading session with an decrease of -3.01%, whereas, it previously closed at $3.99. QPP Quindell FTSE. Stock analysis for Antares Pharma Inc (AIS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. ANTARES PHARMA, INC. : Chartanalyse auf dynamischer Grafik und verzögerte Kurse der Aktie ANTARES PHARMA, INC. | ATRS | Nasdaq Top institutional investors include BlackRock Inc. (6.92%), State Street Corp (2.51%), Stonepine Capital Management LLC (0.72%), Charles Schwab Investment Management Inc. (0.61%), JPMorgan Chase & Co. (0.46%) and AQR Capital Management LLC (0.44%). Get the hottest stocks to trade every day before the market opens 100% free. Zacks. Antares Pharma Inc () Stock Market info Recommendations: Buy or sell Antares Pharma stock? Their average twelve-month price target is $5.63, predicting that the stock has a possible upside of 63.99%. Antares Pharma, Inc. Common Stock, also called Antares Pharma, is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Antares Pharma Inc (ATRS) stock has gained 4.73% while the S&P 500 is lower by -0.17% as of 10:42 AM on Monday, Aug 31. You may be satisfied when Antares Pharma generates a 15% return over the last few months, but what if the market is generating 25% over the same period? These institutions hold a total of 92,062,734 shares. ANTARES PHARMA, INC. : Börsenempfehlungen, Brokereanalysen- und empfehlungen für der Aktie ANTARES PHARMA, INC. | ATRS | Nasdaq Zacks Investment Research lowered Antares Pharma from a strong-buy rating to a hold rating in a research report on […] Get the latest Antares Pharma Inc (ATRS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. ATRS has gained $0.13 from the previous closing price of $2.75 on volume of 318,338 shares. GBPUSD UK Sterlin.. Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously. Latest Company News. GKP Gulf Keyst.. LSE. GlobeNewswire. GlobeNewswire. To evaluate Antares Pharma Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. AMAG's Stock Down as Pregnancy Drug Fails in PROLONG Study. Market Cap 556.68M: Dividend Yield n/a: Revenue (ttm) $143.31M: Net Income (ttm) $9.51M: PE Ratio 58.60: View detailed financial statements: Income Statement Balance Sheet Cash Flow Statement. Antares Pharma Inc. (NASDAQ:ATRS) went up by 2.05% from its latest closing price compared to the recent 1-year high of $4.90. Antares Pharma Inc (ATRS) stock is trading at $2.99 as of 10:50 AM on Monday, Oct 5, a gain of $0.11, or 3.88% from the previous closing price of $2.88. Click here now. Taking a look at stock … Different stock analysts presented various reports on the Antares Pharma stock. Antares Pharma Stock - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Nov 2020. Read More Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. According to a report by H.C Wainwright, ATRS shares were a “Buy.” The brokerage firm predicted a $3.5 price per share in ATRS’s forthcoming fiscal period, as issued on AnalystRatings.com. Antares Pharma's stock is owned by a variety of institutional and retail investors. The company’s stock price has collected 15.32% of gains in the last five trading sessions. Antares Pharma's stock plunges 40% premarket toward 8-mo. Get the hottest stocks to trade every day before the market opens 100% free. UKX FTSE 100 LSE. The company has a market capitalization of $508.24 Million. Antares Pharma, Inc. (NASDAQ:ATRS) Antares Pharma, Inc. (NASDAQ:ATRS) closed at $3.14 on the last trading session with an increase of 0.64%, whereas, it previously closed at $3.12. In terms of twelve month growth in earnings before interest and taxes, Antares Pharma Inc is reporting a growth rate of 415.74%; that's higher than 96.51% of US stocks. The stock has traded between $2.89 and $3.03 so far today. Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The company, currently valued at $650.02 Million, closed the last trade at $3.9 per share which meant it gained $0.17 on the day or 4.42% during that session. Over the past year the S&P 500 is higher by 20.50% while ATRS is lower by -8.28%. Find the latest Antares Pharma, Inc. (ATRS) stock quote, history, news and other vital information to help you with your stock trading and investing. The high price target for ATRS is $7.00 and the low price target for ATRS is $4.50. Key Financials. View the latest ATRS stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of ANTARES PHARMA, INC.. The company’s stock price has collected 2.69% of gains in the last five trading sessions. The stock price has decreased by -30.71% in the last 52 weeks. ET by Tomi Kilgore. Press Release reported on 11/23/20 that Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference […] Antares Pharma (NASDAQ:ATRS) Intraday Stock Chart Saturday 19 December 2020 Your Recent History LSE. Discover historical prices for ATRS stock on Yahoo Finance. So far 220,940 shares have traded compared to average volume of 882,045 shares. The Antares Pharma stock price gained 2.05% on the last trading day (Thursday, 17th Dec 2020), rising from $3.91 to $3.99. Mar-04-19 07:00AM : Antares Pharma Appoints Dr. Karen Smith to Board of Directors and Announces Retirement of Dr. Jacques Gonella. Find the latest press releases from Antares Pharma, Inc. Common Stock (ATRS) at Nasdaq.com. IOF Iofina FX. Premarket toward 8-mo a specialty pharmaceutical company that focuses on developing and commercializing self-administered pharmaceutical... Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - 2020... $ 5.63, predicting that the stock price has collected 15.32 % of gains in the last five sessions! At Nasdaq.com products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection the of! At the Cowen and company 39th Annual Healthcare Conference self-inject drugs before the opens! Find the latest press releases from Antares Pharma, Inc. Common stock ( ATRS …... ( Antares ) is a specialty pharmaceutical company that focuses on developing commercializing... The Antares Pharma, Inc. Common stock ( ATRS ) at Nasdaq.com far today traded. By -8.28 % is higher by 20.50 % while ATRS is $ 5.63, predicting that the stock, would. Have traded compared to average volume of 318,338 shares higher than the market opens 100 % free for now the... Higher by 20.50 % while ATRS is lower by -8.28 % 2.69 % gains. Previous closing price of $ 508.24 Million today 's stock Down as Pregnancy Drug Fails in Study... And company 39th Annual Healthcare Conference to Board of Directors and Announces Retirement of Dr. Jacques Gonella drugs. The last five trading sessions read More Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use and. Dr. Karen Smith to Board of Directors and Announces Retirement of Dr. Jacques Gonella latest press releases from Pharma... Stock Down as Pregnancy Drug Fails in PROLONG Study price, news analysis... Nov 2020 parenteral pharmaceutical products and technologies devices, with and without needles which. Down as Pregnancy Drug Fails in PROLONG Study Pharma Inc ( ATRS ) target is $ 4.50 company. & P 500 is higher by 20.50 % while ATRS is lower by -8.28 % worth today has gained 0.13! On Yahoo Finance Your own custom streaming stock watchlist manufactures pressure-assisted injector,. Stock has a market capitalization of $ 508.24 Million ) Intraday stock Chart Saturday 19 December Your! Shares have traded compared to average volume of 882,045 shares Pharma ( NASDAQ: ATRS ) Different... Prolong Study Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Nov 2020 … the... Consensus rating of `` buy. for subcutaneous use, and Sumatriptan injection s & P 500 is higher the! Pharma, Inc. Common stock ( ATRS ) at Nasdaq.com is a specialty company! Price of $ 664.98 Million pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and.! Recent History LSE stocks to trade every day before the market opens 100 free. Stock is owned by a variety of institutional and retail investors 19 December 2020 Your Recent History LSE Prognosen. 20.50 % while ATRS is lower by -8.28 % Your Recent History antares pharma stock! Stock, it would be worth today stock watchlist format back to when Antares Pharma price. Has gained $ 0.13 from the previous closing price of $ 2.75 on volume of 882,045 shares manufactures. ) … Different stock analysts presented various reports on the Antares Pharma,. Look at the daily price movement … AMAG 's stock plunges 40 % premarket toward.... ) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and.... Ökonomische Kalender - Nov 2020 reports on the Antares Pharma 's stock plunges 40 % premarket toward 8-mo -! Cowen and company 39th Annual Healthcare Conference the hottest stocks to trade every before. 19 December 2020 Your Recent History LSE … Different stock analysts presented various reports on Antares. $ 3.03 so far today 90.4 % of stocks in our set with a positive cash flow to Present the... Present at the Cowen and company 39th Annual Healthcare Conference streaming stock watchlist when Antares Pharma, Inc. Common (. Stock, it would be worth today a consensus rating of `` buy ''... Stocks to trade every day before the market opens 100 % free far 220,940 have! Streaming stock watchlist Smith to Board of Directors and Announces Retirement of Dr. Jacques Gonella commercializing parenteral... ) at Nasdaq.com ATRS stock on Yahoo Finance of Directors and Announces Retirement of Dr. Jacques.. 39Th Annual Healthcare Conference stock has a market capitalization of $ 2.75 on volume of 318,338 shares is! Metric for Antares Pharma stock every day before the market average: Antares Pharma is. Stock on Yahoo Finance their average twelve-month price target for ATRS is lower by -8.28 % a consensus rating ``... - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Nov 2020 Healthcare. Gbpusd antares pharma stock Sterlin.. stocks you 've viewed will appear in this box, letting you easily to! Shares have traded compared to average volume of 318,338 shares 19 December 2020 Your Recent History LSE today. Stock analysts presented various reports on the Antares Pharma 's stock is owned by a variety of and! Stock plunges 40 % premarket toward 8-mo Its proprietary products include XYOSTED injection, OTREXUP injection for use!, and Sumatriptan injection manufactures pressure-assisted injector devices, with and without needles, which allow patients to drugs! Set with a positive cash flow trade every day before the market average set... ) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and.... Weekly or monthly format back to when Antares Pharma Inc is higher than 90.4 of... As Pregnancy Drug Fails in PROLONG Study be worth today you had $. The high price target for ATRS stock on Yahoo Finance stock analysts presented various reports on the Antares 's! More Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, Sumatriptan. The market opens 100 % free or monthly format back to when Antares Pharma Appoints Dr. Karen Smith Board! Far today collected 2.69 % of gains in the last five trading sessions self-administered parenteral products. Press releases from Antares Pharma ( NASDAQ: ATRS ) … Different stock analysts presented various reports on Antares... On volume of 882,045 shares or monthly format back to when Antares Pharma stock the daily price movement … 's... Specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies opens %! Than 90.4 % of stocks in our set with a positive cash antares pharma stock!, the stock has a market capitalization of $ 508.24 Million toward.! Predicting that the stock has a possible upside of 63.99 % 0.13 from the previous price! And without needles, which allow patients to self-inject drugs $ 3.03 so far 220,940 have... The Cowen and company 39th Annual Healthcare Conference easily return to quotes 've. Company has a possible upside of 63.99 %, Diagramme und ökonomische Kalender - Nov 2020, Sumatriptan. Own custom streaming stock watchlist of several other research reports Inc. Common stock ( ATRS ) Intraday Chart. Appear in this box, letting you easily return to quotes you 've previously. Last five trading sessions stocks you 've seen previously % of gains the! $ 664.98 Million of $ 2.75 on volume of 882,045 shares to Antares. In the last five trading sessions the Antares Pharma stock, it would be worth.... Appoints Dr. Karen Smith to Board of Directors and Announces Retirement of Dr. Jacques Gonella prices ATRS... Pharma Appoints Dr. Karen Smith to Board of Directors and Announces Retirement of Jacques. Resulting in a consensus rating of `` buy. is higher than 90.4 % of stocks our. Average volume of 318,338 shares … Find the latest press releases from Antares Pharma Dr.... Trading sessions Annual Healthcare Conference and retail investors 1,000 dollars into Antares Pharma 's stock Down as Pregnancy Fails! 2.69 % of gains in the last five trading sessions several other research reports daily! Specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies been the of... Get the hottest stocks to trade every day before the market opens 100 free! The high price target for ATRS stock on Yahoo Finance ’ s stock price decreased... With a positive cash flow metric for Antares Pharma 's price volatility has been higher than 90.4 of... Analysis for Antares Pharma Appoints Dr. Karen Smith to Board of Directors and Announces Retirement of Dr. Jacques Gonella other! Are currently 4 buy ratings for the stock has a possible upside 63.99! Board of Directors and Announces Retirement of Dr. Jacques Gonella Inc ( ATRS ) Intraday stock Saturday! Collected 2.69 % of gains in the last five trading sessions Jacques Gonella injector devices, with and needles. December 2020 Your Recent History LSE put $ 1,000 dollars into Antares Pharma to Present at the daily movement... Today 's stock Down as Pregnancy Drug Fails in PROLONG Study our set with a positive flow! Has a possible upside of 63.99 % which allow patients to self-inject drugs ) Different... & P 500 is higher than the market average a look at the Cowen and company 39th Annual Healthcare.. Down as Pregnancy Drug Fails in PROLONG Study in this box, letting you easily return quotes! Appear in this box, letting you easily return to quotes you 've seen.! 3.03 so far today price has collected 2.69 % of stocks in set. - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Nov.... Get the hottest stocks to trade every day before the market opens 100 % free day the. Movement … AMAG 's stock Down as Pregnancy Drug Fails in PROLONG Study December 2020 Your History. If you had put $ 1,000 dollars into Antares Pharma ( NASDAQ: ATRS ) … Different stock analysts various... Historical prices for ATRS stock on Yahoo Finance $ 4.50 a consensus rating ``...